Literature DB >> 19455721

Does leptin play a role in obesity-asthma relationship?

Xiao-Mei Mai1, Yue Chen, Daniel Krewski.   

Abstract

The increase of asthma has paralleled the rising obesity during the past decades. Obesity is characterized by the increase of leptin in the circulation. Leptin is an obesity gene product, and it can stimulate the production of pro-inflammatory mediators, such as tumor necrosis factor (TNF)-alpha, interleukin (IL)-6 and interferon (IFN)-gamma. There is a link between leptin and asthma, especially in children. It remains unclear however, if leptin is in the pathway of obesity-asthma relationship and if it plays a distinctive role in asthma in obese vs. non-obese subjects. Since leptin is in a positive feedback loop with the pro-inflammatory cytokines such as TNF-alpha, there is a possibility that leptin is involved as a regulatory rather than an etiologic mechanism of asthma development. Weight loss is associated with decreased circulating leptin concentration in children. Weight control program may need to be considered in the treatment of asthma in obese children.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19455721     DOI: 10.1111/j.1399-3038.2008.00812.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  9 in total

1.  Obese asthmatic patients have decreased surfactant protein A levels: Mechanisms and implications.

Authors:  Njira Lugogo; Dave Francisco; Kenneth J Addison; Akarsh Manne; William Pederson; Jennifer L Ingram; Cynthia L Green; Benjamin T Suratt; James J Lee; Mary E Sunday; Monica Kraft; Julie G Ledford
Journal:  J Allergy Clin Immunol       Date:  2017-06-15       Impact factor: 10.793

2.  Subcutaneous body fat in pregnant New Zealand women: association with wheeze in their infants at 18 months.

Authors:  Patricia Ellyett Watson; Barry William McDonald
Journal:  Matern Child Health J       Date:  2013-07

3.  DNA methylation and genetic polymorphisms of the Leptin gene interact to influence lung function outcomes and asthma at 18 years of age.

Authors:  Nandini Mukherjee; Gabrielle A Lockett; Simon K Merid; Erik Melén; Göran Pershagen; John W Holloway; Syed Hasan Arshad; Susan Ewart; Hongmei Zhang; Wilfried Karmaus
Journal:  Int J Mol Epidemiol Genet       Date:  2016-03-23

4.  Relationship between infant weight gain and later asthma.

Authors:  Ian M Paul; Lindsay Camera; Robert S Zeiger; Theresa W Guilbert; Leonard B Bacharier; Lynn M Taussig; Wayne J Morgan; Ronina A Covar; Marzena Krawiec; Gordon R Bloomberg; David T Mauger
Journal:  Pediatr Allergy Immunol       Date:  2009-08-27       Impact factor: 6.377

5.  Differential epigenome-wide DNA methylation patterns in childhood obesity-associated asthma.

Authors:  Deepa Rastogi; Masako Suzuki; John M Greally
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

6.  Adipokine resistin predicts anti-inflammatory effect of glucocorticoids in asthma.

Authors:  Sirpa Leivo-Korpela; Lauri Lehtimäki; Katriina Vuolteenaho; Riina Nieminen; Hannu Kankaanranta; Seppo Saarelainen; Eeva Moilanen
Journal:  J Inflamm (Lond)       Date:  2011-05-26       Impact factor: 4.981

7.  Leptin/Osteopontin Axis Regulated Type 2T Helper Cell Response in Allergic Rhinitis with Obesity.

Authors:  Qingxiang Zeng; Xi Luo; Miaomiao Han; Wenlong Liu; Huabin Li
Journal:  EBioMedicine       Date:  2018-06-07       Impact factor: 8.143

Review 8.  Obesity-Related Asthma: Immune Regulation and Potential Targeted Therapies.

Authors:  Yuze Yuan; Nan Ran; Lingxin Xiong; Guoqiang Wang; Xuewa Guan; Ziyan Wang; Yingqiao Guo; Zhiqiang Pang; Keyong Fang; Junying Lu; Chao Zhang; Ruipeng Zheng; Jingtong Zheng; Jie Ma; Fang Wang
Journal:  J Immunol Res       Date:  2018-06-28       Impact factor: 4.818

9.  Role of Leptin/Osteopontin Axis in the Function of Eosinophils in Allergic Rhinitis with Obesity.

Authors:  Wenlong Liu; Qingxiang Zeng; Yanqiu Chen; Ren Zhong Luo
Journal:  Mediators Inflamm       Date:  2018-10-24       Impact factor: 4.711

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.